Last reviewed · How we verify
Serum Free Avonex
At a glance
| Generic name | Serum Free Avonex |
|---|---|
| Also known as | Avonex |
| Sponsor | Biogen |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers (PHASE1)
- Immunogenicity and Safety Study of Serum-Free Avonex (PHASE2)
- A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Serum Free Avonex CI brief — competitive landscape report
- Serum Free Avonex updates RSS · CI watch RSS
- Biogen portfolio CI